242 related articles for article (PubMed ID: 30170977)
21. The reality of cholangiocarcinoma in India- real world data from a tertiary referral centre.
Patkar S; Gupta V; Khobragade K; Goel M
HPB (Oxford); 2022 Sep; 24(9):1511-1518. PubMed ID: 35379594
[TBL] [Abstract][Full Text] [Related]
22. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of liver surgery: A decade of mandatory nationwide auditing in the Netherlands.
de Graaff MR; Klaase JM; Dulk MD; Buis CI; Derksen WJM; Hagendoorn J; Leclercq WKG; Liem MSL; Hartgrink HH; Swijnenburg RJ; Vermaas M; Belt EJT; Bosscha K; Verhoef C; Olde Damink S; Kuhlmann K; Marsman HM; Ayez N; van Duijvendijk P; van den Boezem P; Manusama ER; Grünhagen DJ; Kok NFM;
Eur J Surg Oncol; 2024 Jun; 50(6):108264. PubMed ID: 38537366
[TBL] [Abstract][Full Text] [Related]
24. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
[TBL] [Abstract][Full Text] [Related]
25. Gallbladder cancer mimicking perihilar cholangiocarcinoma-considerable rate of postoperative reclassification with implications for prognosis.
Nooijen LE; Gustafsson-Liljefors M; Erdmann JI; D'Souza MA; Gilg S; Villard C; Jansson H
World J Surg Oncol; 2023 Sep; 21(1):286. PubMed ID: 37697321
[TBL] [Abstract][Full Text] [Related]
26. Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies.
Kriegsmann M; Roessler S; Kriegsmann K; Renner M; Longuespée R; Albrecht T; Loeffler M; Singer S; Mehrabi A; Vogel MN; Pathil A; Köhler B; Springfeld C; Rupp C; Weiss KH; Goeppert B
BMC Cancer; 2019 Jan; 19(1):72. PubMed ID: 30646854
[TBL] [Abstract][Full Text] [Related]
27. DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.
Nevi L; Di Matteo S; Carpino G; Zizzari IG; Samira S; Ambrosino V; Costantini D; Overi D; Giancotti A; Monti M; Bosco D; De Peppo V; Oddi A; De Rose AM; Melandro F; Bragazzi MC; Faccioli J; Massironi S; Grazi GL; Panici PB; Berloco PB; Giuliante F; Cardinale V; Invernizzi P; Caretti G; Gaudio E; Alvaro D
Hepatology; 2021 Jan; 73(1):144-159. PubMed ID: 32978808
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
[TBL] [Abstract][Full Text] [Related]
29. Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.
Mancinelli R; Cutone A; Rosa L; Lepanto MS; Onori P; Pannarale L; Franchitto A; Gaudio E; Valenti P
Eur J Histochem; 2020 Oct; 64(4):. PubMed ID: 33131269
[TBL] [Abstract][Full Text] [Related]
30. [Klatskin tumor: long-term survival following surgery].
Juntermanns B; Fingas CD; Sotiropoulos GC; Jaradat D; Dechêne A; Reis H; Kasper S; Paul A; Kaiser GM
Chirurg; 2016 Jun; 87(6):514-9. PubMed ID: 27090415
[TBL] [Abstract][Full Text] [Related]
31. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
[TBL] [Abstract][Full Text] [Related]
32. Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers.
Liao H; Chen X; Wang H; Lin Y; Chen L; Yuan K; Liao M; Jiang H; Peng J; Wu Z; Huang J; Li J; Zeng Y
Cancer Res; 2024 Jun; 84(11):1747-1763. PubMed ID: 38471085
[TBL] [Abstract][Full Text] [Related]
33. Galanin System in the Human Bile Duct and Perihilar Cholangiocarcinoma.
Huber S; Fitzner T; Feichtinger RG; Hochmann S; Kraus T; Sotlar K; Kofler B; Varga M
Cells; 2023 Jun; 12(13):. PubMed ID: 37443714
[TBL] [Abstract][Full Text] [Related]
34. The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers.
Zhang Y; Ma Z; Li C; Wang C; Jiang W; Chang J; Han S; Lu Z; Shao Z; Wang Y; Wang H; Jiao C; Wang D; Wu X; Shen H; Wang X; Hu Z; Li X
Nat Commun; 2022 Jun; 13(1):3061. PubMed ID: 35650238
[TBL] [Abstract][Full Text] [Related]
35. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
[TBL] [Abstract][Full Text] [Related]
36. PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.
Fontugne J; Augustin J; Pujals A; Compagnon P; Rousseau B; Luciani A; Tournigand C; Cherqui D; Azoulay D; Pawlotsky JM; Calderaro J
Oncotarget; 2017 Apr; 8(15):24644-24651. PubMed ID: 28445951
[TBL] [Abstract][Full Text] [Related]
37. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract][Full Text] [Related]
38. Transparenchymal glissonean approach: a novel surgical technique for advanced perihilar bile duct cancer.
Kamachi H; Kamiyama T; Tsuruga Y; Orimo T; Wakayama K; Shimada S; Kakisaka T; Yokoo H; Yamashita K; Taketomi A
Langenbecks Arch Surg; 2018 May; 403(3):387-394. PubMed ID: 29063245
[TBL] [Abstract][Full Text] [Related]
39. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
40. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
